Davis's Drug Guide
lepirudin (rDNA)
General
High Alert Medication: This medication bears a heightened risk of causing significant patient harm when it is used in error.
**Off Market Drug**
This medication is no longer available in the United States. Information provided here is for reference purposes only.
Pronunciation:
le-peer-yoo-din
To hear audio pronunciation of this topic, purchase a subscription or log in.Trade Name(s)
- Refludan
Ther. Class.
Pharm. Class.
thrombin inhibitors
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., et al. "Lepirudin (rDNA)." Davis's Drug Guide, 19th ed., F.A. Davis Company, 2026. The Washington Manual, www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/51437/all/lepirudin__rDNA_.
Vallerand AHA, Sanoski CAC, . Lepirudin (rDNA). Davis's Drug Guide. F.A. Davis Company; 2026. https://www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/51437/all/lepirudin__rDNA_. Accessed April 26, 2026.
Vallerand, A. H., Sanoski, C. A., & , (2026). Lepirudin (rDNA). In Davis's Drug Guide (19th ed.). F.A. Davis Company. https://www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/51437/all/lepirudin__rDNA_
Vallerand AHA, Sanoski CAC, . Lepirudin (rDNA) [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2026. [cited 2026 April 26]. Available from: https://www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/51437/all/lepirudin__rDNA_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - lepirudin (rDNA)
ID - 51437
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
AU - ,,
BT - Davis's Drug Guide
UR - https://www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/51437/all/lepirudin__rDNA_
PB - F.A. Davis Company
ET - 19
DB - The Washington Manual
DP - Unbound Medicine
ER -
